(Q43243045)

17 November 2017

title

Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue (English)

1 reference

17 November 2017

6

G M Reaven

1 reference

17 November 2017

Tracey M McLaughlin

1

1 reference

17 November 2017

T Liu

2

1 reference

17 November 2017

Gail Yee

3

1 reference

17 November 2017

F Abbasi

4

1 reference

17 November 2017

C Lamendola

5

1 reference

17 November 2017

P Tsao

7

1 reference

17 November 2017

S W Cushman

8

1 reference

17 November 2017

A Sherman

9

1 reference

17 November 2017

publication date

12 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

18

1 reference

17 November 2017

issue

5

1 reference

17 November 2017

page(s)

926-931

1 reference

Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effects of Chronic Rosiglitazone Therapy on Gene Expression in Human Adipose Tissuein Vivoin Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Failure of adipocyte differentiation causes type II diabetes mellitus?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Effect of troglitazone on body fat distribution in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

7 January 2021

Insulin resistance as a predictor of age-related diseases

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

7 January 2021

Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

7 January 2021

Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

7 January 2021

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.380

7 January 2021

Identifiers

DOI

10.1038/OBY.2009.380

1 reference

17 November 2017

1 reference